Stem cell therapies in the Golden State might soon see the light of day—and the clinic. The California Institute for Regenerative Medicine (CIRM) announced last month that it will contribute up to $50 million toward early-stage clinical trials for cells derived from embryonic or induced pluripotent stem cells. (Click here to continue reading)

See also: A timeline of new CIRM funding initiatives